semaglutide cardiovascular outcomes news 2025 october 🔴Cardiovascular with by severity of chronic kidney disease in type 2 diabetes: the FLOW trial⤵️ 🔹Semaglutide significantly reduced the risk of CV death/MI/stroke regardless of baseline CKD severity in participants Weight-loss drug tied to lower

However, experts have warned the approach is dangerous, with some people taking unlicensed versions of semaglutide ending up needing emergency hospital care after buying from unregulated online sellers without a prescription

When we lose weight quickly, we also wind up with extra sagging skin in the belly, breasts, and possibly and arms and thighs

Otherwise, you risk taking too many doses too close together

Womans World wants to hear YOUR experiences with tirzepatide, semaglutide, and your experiences with prescription weight loss or telehealth in general

The more important question is: how much of the supplement actually reaches your cells